Small Pharma Reports Highlights for the Fiscal Year Ended February 28, 2022
Small Pharma reports highlights for the fiscal year ended February 2022, including its financial results.
Small Pharma Shares Business Update Ahead of Annual Financial Results
Small Pharma shares business update ahead of annual financial results, including a new COO appointment.
Small Pharma Reports Fiscal Third Quarter 2021 Highlights
Significant progress made across the clinical portfolio with lead candidate advancing through trials January 31,…
The Dales Report lists Small Pharma as one of 10 Psychedelic Companies To Watch In 2022
Small Pharma (CVE: DMT) (OTCMKTS: DMTTF) are delighted to be highlighted as one of the…
The Sifted Podcast Episode Two: The Companies Going Psychedelic
In this episode, you’ll hear from Dr Carol Routledge, Chief Medical and Scientific Officer at…
Small Pharma reports second quarter highlights
LONDON, Sept. 21, 2021 /PRNewswire/ -- Small Pharma Inc. (TSXV: DMT) (the "Company" or "Small…
Small Pharma to restate financial statements to reflect IFRS fair value of convertible notes and share options
LONDON, Sept. 21, 2021 /PRNewswire/ -- Small Pharma Inc. (TSXV: DMT) (the "Company" or "Small…
13 Oct 21 – KCSA Virtual Investor Conference
10:00 A.M. ET Presentation: Small Pharma’s progress in the development of N,N-dimethyltryptamine (“DMT”) assisted therapy…
Small Pharma reports first fiscal quarter 2021 highlights
Small Pharma Inc. (TSXV: DMT) (the “Company” or “Small Pharma”), a neuropharmaceutical company focused on…
Small Pharma Inc. to commence trading on the TSX Venture Exchange on May 6, 2021
May 4, 2021 (GLOBE NEWSWIRE) – Vancouver, British Columbia – Small Pharma Inc. (formerly Unilock…